Summit jumps as FICO falls on mortgage scoring changes
Summit gained after AstraZeneca agreed to invest $2 billion, while CarMax beat earnings forecasts and FICO faced a new scoring framework.
Makkler Newsroom · Sep 29, 02:57 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $61.00 (+14.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO